We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Top Sells

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$63.6M
2
CMCSA icon
Comcast
CMCSA
+$39.7M
3
EVRG icon
Evergy
EVRG
+$38.5M
4
PEG icon
Public Service Enterprise Group
PEG
+$38.4M
5
TECH icon
Bio-Techne
TECH
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UWMC icon
2126
UWM Holdings
UWMC
$2.41B
$113K ﹤0.01%
+13,362
New +$112K
VHC icon
2127
VirnetX Holding Corp
VHC
$53.8M
$113K ﹤0.01%
1,329
-1,141
-46% -$107K
CSLT
2128
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$111K ﹤0.01%
42,095
-295,900
-88% -$551K
LONA
2129
LeonaBio Inc
LONA
$75.2M
$110K ﹤0.01%
+1,070
New +$187K
PRFZ icon
2130
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.85B
$110K ﹤0.01%
+2,940
New +$108K
AWH
2131
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$110K ﹤0.01%
+1,303
New +$112K
AGRX
2132
DELISTED
Agile Therapeutics
AGRX
$109K ﹤0.01%
41
+32
+356% +$106K
ARVLW
2133
DELISTED
Arrival Warrant
ARVLW
$107K ﹤0.01%
+24,900
New +$146K
DHX icon
2134
DHI Group
DHX
$192M
$106K ﹤0.01%
+31,224
New +$98.9K
SIOX
2135
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$106K ﹤0.01%
39,007
+26,111
+202% +$64.9K
IRON icon
2136
Disc Medicine
IRON
$3.18B
$105K ﹤0.01%
543
-1,439
-73% -$473K
DHS icon
2137
WisdomTree US High Dividend Fund
DHS
$1.61B
$104K ﹤0.01%
+1,331
New +$105K
BBD icon
2138
Banco Bradesco
BBD
$34.7B
$103K ﹤0.01%
22,017
+9,331
+74% +$40.6K
APTX
2139
DELISTED
Aptinyx Inc. Common Stock
APTX
$103K ﹤0.01%
36,332
+16,935
+87% +$47.3K
SVFB
2140
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$100K ﹤0.01%
10,000
– –
YELL
2141
DELISTED
Yellow Corporation Common Stock
YELL
$100K ﹤0.01%
15,384
-112,956
-88% -$841K
SYM icon
2142
Symbotic
SYM
$5.3B
$99K ﹤0.01%
10,000
– –
TAST
2143
DELISTED
Carrols Restaurant Group, Inc.
TAST
$99K ﹤0.01%
16,408
-6,485
-28% -$38.3K
EXK
2144
Endeavour Silver
EXK
$3.27B
$98K ﹤0.01%
+16,027
New +$100K
TUFN
2145
DELISTED
Tufin Software Technologies Ltd.
TUFN
$98K ﹤0.01%
10,700
-33,935
-76% -$318K
EES icon
2146
WisdomTree US SmallCap Earnings Fund
EES
$719M
$97K ﹤0.01%
+1,973
New +$96.8K
CNSL
2147
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$97K ﹤0.01%
+11,015
New +$88.5K
STSA
2148
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$95K ﹤0.01%
+13,474
New +$72.6K
WNEB icon
2149
Western New England Bancorp
WNEB
$277M
$94K ﹤0.01%
+11,552
New +$95.5K
OIG
2150
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$94K ﹤0.01%
535
-806
-60% -$141K
84 85
86
87 88

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.